Hepatic hemangiomas are benign tumors occurring in the endothelial cells of the hepatic blood vessels and do not require treatment in patients who are asymptomatic or small in size. When symptoms are obvious, targeted drugs and propranolol can be used for treatment. 1. Some targeted drugs: such as common sorafenib, bevacizumab, etc., can effectively reduce the size of hepatic hemangioma, but the specific efficacy of the treatment needs further research. 2. Propranolol: it has certain efficacy for some infants and young children with hepatic hemangioma, but for other patients with hepatic hemangioma, the efficacy has not been determined. Since the therapeutic effect of drugs for hepatic hemangioma has not been determined, clinically, if the patient’s symptoms are obvious and the tumor volume is large, surgery is generally preferred for treatment; surgical treatments include hepatic hemangioma resection, partial hepatectomy, regular hepatectomy, hepatic artery ligation, liver transplantation and so on. Therefore, when patients have hepatic hemangioma, it is better to go to the hospital in time, and choose the appropriate method for treatment under the guidance of the doctor by fully combining the patient’s condition.